Tailored Breast Cancer Screening; Nov. 27, 2:00pm-3:30pm

This session considers risk assessment for breast cancer screening, protocols for screening beyond mammography and current controversies in breast cancer screening.

When: Sunday, Nov. 27, 2:00-3:30pm
Where: S406B

Speaker information:
Mark E. Robson, MD, clinical director clinical genetics service, Memorial Sloan-Kettering Cancer Center, New York City
D. David Dershaw, MD, director, breast imaging, Memorial Sloan-Kettering Cancer Center, New York City
Daniel B. Kopans, MD, director, breast imaging, Massachusetts General Hospital, Boston

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.